Identifying and developing new drugs and conducting clinical trials involve complex and lengthy (i.e., costly) processes that require researchers and drug manufacturers to integrate, manage, and analyze incredible amounts of data while at the same time collaborate with other medical research and pharma companies in their efforts. Pharmaceutical and biotechnology companies are using artificial intelligence (AI) to optimize the discovery and evaluation of new drug compounds, to explore patient and efficacy data, and to develop and bring new therapies to market.